Several inborn errors of metabolism (IEM) are associated with endocrine dysfunction, especially those involving energy deficiency (respiratory chain defects) and storage disorders (cystinosis). Long-term consequences on growth, bone metabolism, and fertility are still poorly understood (Vantyghem et al. 2012) .
This themed issue on BDiabetes and Metabolism^focuses on some of the major metabolic pathways implicated in the pathogenesis of type 2 diabetes mellitus (T2DM), a new and growing field of investigation. The review BMetabolic Pathways at the Crossroads of Diabetes and Inborn Errorsê xamines whether many of the biochemical changes observed in the prediabetic state (i.e., ectopic lipid storage, increased acylcarnitines, increased branched-chain amino acids) are also observed in patients with rare inborn errors of fatty acid and amino acid metabolism, and if the accumulation of specific metabolic intermediates confers increased risk for diabetes (Goetzman et al. 2017) . The evidence of a link between acyl-CoA dehydrogenase (ACAD)10 deficiency in mice, showing increased long-chain acylcarnitines, impaired glucose tolerance, peripheral insulin resistance, and abnormal weight gain, is presented in BInvestigating the link of ACAD10 deficiency to type 2 diabetes mellitus^ (Bloom et al. 2017) . A tantalizing link of an ACAD10 gene polymorphism to the development of T2DM in a high-risk population emphasizes the need for further study of the function of this enzyme. Since metabolic-disorder-induced oxidative stress is known to attack cellular proteins, lipids, and nucleic acids, leading to cellular dysfunction, the physiological relevance of protein carbonylation reviewed in BRole of protein carbonylation in diabetes^ (Hecker and Wagner 2017) is of relevance to the topic of this issue. The degree of acyl modification of proteins was investigated in the study BLoss of sirtuin 4 in mice leads to elevated glucose-and leucinestimulated insulin levels in vivo and accelerated ageinduced insulin resistance across different genetic backgrounds^ (Huynh et al. 2017) . Its potential physiologic relevance as a novel contributor to T2DM introduces an additional opportunity to explore a previously unrecognized component of this disease. Whether low enzyme activity may impede the increased risk of diabetes or is more likely the cause of the inherited metabolic disorder carnosinemia is discussed in the review BCarnosinase, diabetes mellitus and the potential value of enzyme deficiency^ (Peters et al. 2017) . How detailed clarification of the pathophysiology of diabetes subtypes has changed the understanding of DM in children, allowing more precise and individualized therapies, is summarized in the review BUnderstanding childhood diabetes mellitus: new pathophysiological aspects^(GrulichHenn and Klose 2017). Due to the rising prevalence of obesity in children, it is important to consider the impact of obesity and its relevance to metabolic function. The article BLipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes ( Seyfarth et al. 2017 ) addresses this question. Continuing research is needed to understand the complexities of metabolic disruption and compensatory responses in IEMs and how these responses overlap with T2DM.
The tantalizing conclusion from the articles in this special edition is that T2DM may be a half-way point between normal glucose homeostasis and some IEMs and that variation in the function of some enzymes may be one component of the multifactorial etiology of T2DM. There will be much to watch in this field of research going forward.
